Lund, SwedenNov 2021
Asgard Therapeutics raised €6.0M in a Seed round in Nov 2021. The company is based in Lund, Sweden. Investors in the round: Boehringer Ingelheim Venture Fund, Industrifonden, Novo Holdings. Data as of Nov 2026.
Amount raised
€6.0M
€6,000,000
Native amount
6,000,000 EUR
Stage
Seed
seed
Investors
3
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €6.0M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Nov 2021
Round type
seed
Amount (EUR)
€6.0M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Novo Holdings co-Leads EUR6m seed financing in Asgard Therapeuticsprivateequitywire.co.uk · 2021-11